AVTE
Price
$2.55
Change
-$0.01 (-0.39%)
Updated
Dec 18, 04:06 PM (EDT)
98 days until earnings call
DNLI
Price
$21.82
Change
-$1.40 (-6.03%)
Updated
Dec 18, 04:12 PM (EDT)
75 days until earnings call
Ad is loading...

AVTE vs DNLI

Header iconAVTE vs DNLI Comparison
Open Charts AVTE vs DNLIBanner chart's image
Aerovate Therapeutics
Price$2.55
Change-$0.01 (-0.39%)
Volume$759
CapitalizationN/A
Denali Therapeutics
Price$21.82
Change-$1.40 (-6.03%)
Volume$1.32K
CapitalizationN/A
AVTE vs DNLI Comparison Chart
Loading...
AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTE vs. DNLI commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTE is a Hold and DNLI is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (AVTE: $2.56 vs. DNLI: $23.22)
Brand notoriety: AVTE and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTE: 9% vs. DNLI: 176%
Market capitalization -- AVTE: $74.01M vs. DNLI: $3.34B
AVTE [@Biotechnology] is valued at $74.01M. DNLI’s [@Biotechnology] market capitalization is $3.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTE’s FA Score shows that 1 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • AVTE’s FA Score: 1 green, 4 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, AVTE is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTE’s TA Score shows that 2 TA indicator(s) are bullish while DNLI’s TA Score has 2 bullish TA indicator(s).

  • AVTE’s TA Score: 2 bullish, 4 bearish.
  • DNLI’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, AVTE is a better buy in the short-term than DNLI.

Price Growth

AVTE (@Biotechnology) experienced а -2.66% price change this week, while DNLI (@Biotechnology) price change was -5.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.43%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

AVTE is expected to report earnings on Mar 26, 2025.

DNLI is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.34B) has a higher market cap than AVTE($74M). DNLI YTD gains are higher at: 8.201 vs. AVTE (-88.688). AVTE has higher annual earnings (EBITDA): -89.96M vs. DNLI (-496.05M). DNLI has more cash in the bank: 837M vs. AVTE (88.7M). AVTE has less debt than DNLI: AVTE (540K) vs DNLI (52.5M). AVTE (0) and DNLI (0) have equivalent revenues.
AVTEDNLIAVTE / DNLI
Capitalization74M3.34B2%
EBITDA-89.96M-496.05M18%
Gain YTD-88.6888.201-1,081%
P/E RatioN/AN/A-
Revenue00-
Total Cash88.7M837M11%
Total Debt540K52.5M1%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVTEDNLI
RSI
ODDS (%)
N/A
Bearish Trend 6 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 10 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
78%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSVRX17.51N/A
N/A
PGIM Quant Solutions Small-Cap Val R
RPEBX65.85-0.16
-0.24%
American Funds New Perspective R2E
IRSAX15.30-0.05
-0.33%
Delaware Real Estate Securities A
HCPCX55.04-0.22
-0.40%
Hartford Capital Appreciation HLS IC
WFDSX32.56-0.27
-0.82%
Allspring SMID Cap Growth Fund - Cl Inst

AVTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTE has been closely correlated with OVID. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if AVTE jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTE
1D Price
Change %
AVTE100%
N/A
OVID - AVTE
90%
Closely correlated
+0.95%
NTLA - AVTE
46%
Loosely correlated
-1.87%
DNLI - AVTE
43%
Loosely correlated
-0.30%
BEAM - AVTE
41%
Loosely correlated
-1.21%
SNDX - AVTE
39%
Loosely correlated
-1.16%
More

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-0.30%
BEAM - DNLI
64%
Loosely correlated
-1.21%
JANX - DNLI
55%
Loosely correlated
-3.17%
NTLA - DNLI
55%
Loosely correlated
-1.87%
RCKT - DNLI
53%
Loosely correlated
+1.36%
LGND - DNLI
52%
Loosely correlated
-1.56%
More